These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21407890)

  • 21. Venlafaxine:a novel antidepressant compound.
    Schweizer E; Thielen RJ; Frazer A
    Expert Opin Investig Drugs; 1997 Jan; 6(1):65-78. PubMed ID: 15989562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
    Horst WD; Preskorn SH
    J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms.
    Reznik I; Rosen Y; Rosen B
    J Psychopharmacol; 1999; 13(2):193-5. PubMed ID: 10475726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic profile and efficacy of venlafaxine.
    Mendlewicz J
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():5-13. PubMed ID: 7622816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kleptomania Induced by Venlafaxine.
    Sakurada K; Nibuya M; Yamada K; Nakagawa S; Suzuki E
    Case Rep Psychiatry; 2021; 2021():8470045. PubMed ID: 34540303
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe hypertriglyceridemia secondary to venlafaxine use in an older adult on dialysis -case report.
    Lin HW; Simonavice CA; Lu CR; Lin WL; Wu PL; Chou CY; Liao CH; Lane HY
    BMC Health Serv Res; 2017 Apr; 17(1):272. PubMed ID: 28407764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of neuropeptides in antidepressant and memory improving effects of venlafaxine.
    Nowakowska E; Kus K; Bobkiewicz-Kozłowska T; Hertmanowska H
    Pol J Pharmacol; 2002; 54(6):605-13. PubMed ID: 12866715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O; Szegedi A; Philipp M; Kohnen R; Heinrich C; Heukels A; van der Vegte-Senden M; Baker RA; Simmons JH; Schutte AJ
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the antidepressant venlafaxine on fish brain serotonin and predation behavior.
    Bisesi JH; Bridges W; Klaine SJ
    Aquat Toxicol; 2014 Mar; 148():130-8. PubMed ID: 24486880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antidepressants venlafaxine ("Effexor") and fluoxetine ("Prozac") produce different effects on locomotion in two species of marine snail, the oyster drill (Urosalpinx cinerea) and the starsnail (Lithopoma americanum).
    Fong PP; Bury TB; Dworkin-Brodsky AD; Jasion CM; Kell RC
    Mar Environ Res; 2015 Feb; 103():89-94. PubMed ID: 25481651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of indoleamine 2, 3- dioxygenase pathway by olanzapine augments antidepressant effects of venlafaxine in mice.
    Thomas J; Khanam R; Vohora D
    Psychiatry Res; 2017 Dec; 258():444-448. PubMed ID: 28911850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.
    Berrocoso E; Mico JA
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):61-71. PubMed ID: 18405417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venlafaxine-induced cholestatic hepatitis: case report and review of literature.
    Stadlmann S; Portmann S; Tschopp S; Terracciano LM
    Am J Surg Pathol; 2012 Nov; 36(11):1724-8. PubMed ID: 23073329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seizures associated with therapeutic doses of venlafaxine and trimipramine.
    Schlienger RG; Klink MH; Eggenberger C; Drewe J
    Ann Pharmacother; 2000 Dec; 34(12):1402-5. PubMed ID: 11144696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid onset of action of venlafaxine.
    Montgomery SA
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic action lag time and resistance to treatment].
    Peretti CS
    Encephale; 1999 Jun; 25 Spec No 2():49-54. PubMed ID: 10434159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
    Fatemi SH; Emamian ES; Kist DA
    Ann Pharmacother; 1999 Jun; 33(6):701-3. PubMed ID: 10410184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR; Nemeroff CB
    Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
    DeVane CL; Donovan JL; Liston HL; Markowitz JS; Cheng KT; Risch SC; Willard L
    J Clin Psychopharmacol; 2004 Feb; 24(1):4-10. PubMed ID: 14709940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobiologic basis of antidepressant safety profiles.
    Hackett D; Salinas E
    Eur Psychiatry; 1997; 12 Suppl 4():301s-6s. PubMed ID: 19698584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.